ISC West: IDEMIA's Teresa Wu on Mobile ID's Big Moment, Education, and Frictionless Biometrics
Summary
**EPISODE LINKS** Learn more about IDEMIA: https://www.idemia.com/ Register for the Travel & Hospitality Identity Summit: https://events.channelpronetwork.com/travel-hospitality-biometrics-online-summit Download the FindBiometrics Year in Review Report: https://findbiometrics.com/face-biometrics-privacy-and-finance-download-the-19th-annual-findbiometrics-year-in-review-report/ Live from ISC West 2022: FindBiometrics Director of Digital Media and Events Doug OGorden speaks with renowned identity expert Teresa Wu, Vice President of Innovation and Client Engagement at IDEMIA. The conversation begins where OGorden’s previous interview with IDEMIA left off: on the importance of frictionless biometrics, before shifting to talk about the company’s relationship with TSA and biometrics in aviation. Wu goes on to comment on the breaking news of Apple’s Arizona mobile ID launch, discusses privacy and education issues around biometrics, and lets us in on what’s next from IDEMIA.
**EPISODE LINKS**
Learn more about IDEMIA: https://www.idemia.com/
Register for the Travel & Hospitality Identity Summit: https://events.channelpronetwork.com/travel-hospitality-biometrics-online-summit
Download the FindBiometrics Year in Review Report: https://findbiometrics.com/face-biometrics-privacy-and-finance-download-the-19th-annual-findbiometrics-year-in-review-report/
Live from ISC West 2022: FindBiometrics Director of Digital Media and Events Doug OGorden speaks with renowned identity expert Teresa Wu, Vice President of Innovation and Client Engagement at IDEMIA.
The conversation begins where OGorden’s previous interview with IDEMIA left off: on the importance of frictionless biometrics, before shifting to talk about the company’s relationship with TSA and biometrics in aviation. Wu goes on to comment on the breaking news of Apple’s Arizona mobile ID launch, discusses privacy and education issues around biometrics, and lets us in on what’s next from IDEMIA.